HomeCompareAVGR vs MAIN

AVGR vs MAIN: Dividend Comparison 2026

AVGR yields 421.94% · MAIN yields 6.91%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $42.66M in total portfolio value· pulled ahead in Year 7
10 years
AVGR
AVGR
● Live price
421.94%
Share price
$0.47
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228.6K
Annual income
$477.83
Full AVGR calculator →
MAIN
Main Street Capital Corporation
● Live price
6.91%
Share price
$52.96
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.89M
Annual income
$35,818,348.00
Full MAIN calculator →

Portfolio growth — AVGR vs MAIN

📍 MAIN pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVGRMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVGR + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVGR pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVGR
Annual income on $10K today (after 15% tax)
$35,864.98/yr
After 10yr DRIP, annual income (after tax)
$406.16/yr
MAIN
Annual income on $10K today (after 15% tax)
$587.42/yr
After 10yr DRIP, annual income (after tax)
$30,445,595.80/yr
At 15% tax rate, MAIN beats the other by $30,445,189.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVGR + MAIN for your $10,000?

AVGR: 50%MAIN: 50%
100% MAIN50/50100% AVGR
Portfolio after 10yr
$21.56M
Annual income
$17,909,412.92/yr
Blended yield
83.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AVGR right now

AVGR
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-48.2
Piotroski
4/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+23.2% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVGR buys
0
MAIN buys
0
No recent congressional trades found for AVGR or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVGRMAIN
Forward yield421.94%6.91%
Annual dividend / share$2.00$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%72.7%
Portfolio after 10y$228.6K$42.89M
Annual income after 10y$477.83$35,818,348.00
Total dividends collected$131.1K$41.85M
Payment frequencyquarterlymonthly
SectorStockBDC
Analyst consensusBuyHold

Year-by-year: AVGR vs MAIN ($10,000, DRIP)

YearAVGR PortfolioAVGR Income/yrMAIN PortfolioMAIN Income/yrGap
1$31,797$21,097.05$12,434$1,193.51+$19.4KAVGR
2$65,370$31,346.90$16,255$2,280.05+$49.1KAVGR
3$100,060$30,114.17$22,851$4,580.08+$77.2KAVGR
4$128,604$21,539.72$35,577$9,892.59+$93.0KAVGR
5$150,543$12,936.60$63,653$23,664.70+$86.9KAVGR
6$168,157$7,076.40$136,601$65,054.52+$31.6KAVGR
7← crossover$183,622$3,693.63$368,044$214,504.02$184.4KMAIN
8$198,360$1,884.73$1,301,668$887,987.40$1.10MMAIN
9$213,196$951.40$6,288,483$4,825,407.47$6.08MMAIN
10$228,598$477.83$42,886,603$35,818,348.00$42.66MMAIN

AVGR vs MAIN: Complete Analysis 2026

AVGRStock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Full AVGR Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this AVGR vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVGR vs SCHDAVGR vs JEPIAVGR vs OAVGR vs KOAVGR vs ARCCAVGR vs HTGCAVGR vs GBDCAVGR vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.